H
Hinoman
Cultivating Mankai, a whole plant-based protein ingredient, using sustainable agriculture
About Hinoman
Hinoman is a pioneering company in the plant-based nutrition sector, focusing on the cultivation and commercialization of Mankai, an ancient green plant. Mankai is unique in that it contains complete protein with all nine essential amino acids, iron, and vitamin B12, along with numerous other key nutrients. The company operates in the health and wellness market, targeting consumers seeking healthy, secure, and sustainable food options. Hinoman's business model revolves around the production and sale of Mankai, leveraging breakthrough technology to ensure high nutritional value and sustainability. Revenue is generated through direct sales to consumers, partnerships with food manufacturers, and collaborations with health and wellness brands. The company's innovative approach has shown promising results in clinical trials, demonstrating benefits such as improved blood glucose control and iron absorption.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Beersheba, Israel
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 24.0/100
- Sub-industry
- AgriTech, Innovative Food
- Sector
- Food, Diabetes, Biotechnology, Algae, Precision Agriculture, Hydroponics, Superfood, Cultivation, Nutrition, Chemical, Plant-Based
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2017 | $15M | $60M | Ajinomoto | — |
Growth signals
Latest recorded traffic for Hinoman is 4.2K monthly website visits, up 8300% over the last three months. Hinoman's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Ajinomoto
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hinoman on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hinoman’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.